Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions support the article’s findings by highlighting that treatment in jail reduces recidivism and mortality, with language like 'treatment works' and 'illegal to deny access' showing strong approval. The tone is affirmative and advocacy-oriented, emphasizing the potential to improve outcomes and influence policies, which reflects a moderate but meaningful level of engagement and impact.
Most discussions express strong support for providing buprenorphine in jail and acknowledge its benefits, reflecting agreement with the publication's findings.
The discussions show high interest, as they focus on the importance of medication-assisted treatment and its implications in criminal justice settings.
Participants reference specific research results and advocate for policy changes, indicating moderate but meaningful engagement.
The emphasis on legal rights and policy implications suggests the discussions could influence health and criminal justice practices, indicating a noticeable impact.
Episode 16: “Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder” from @DrugAlcoholDep: Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Drug and Alcohol Dependence, Volume 231, 2022, 109254, ISSN 0376-8716. https://t.co/hzshZ2wuCm
The next Addiction Medicine Journal Club podcast is coming on Monday. Download the article from @DrugAlcoholDep now so you can join the conversation. “Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.” https://t.co/hzshZ2x2rU
Treatment for opioid use disorder in jail works, and denying it is illegal! Episode 16 reviews an article about in-jail #buprenorphine. Listen on any podcast app. #opioidusedisorder #americanswithdisabilitiesact #AMJC #addictionmedicine https://t.co/hzshZ2x2rU
RT @jcoinctc: Results from a recent #JCOIN study found that among incarcerated adults with OUD, the risk of recidivism after jail exit is l…
1.https://t.co/2Nk0bCyeN4 2.https://t.co/lvnApkYcvD @UNODC_PTRS @WHO @MVDrugCourt @StateINL @hrcmv
Read newly publlshed article addressing the use of buprenorphine in jail for reducing recidivism and death: https://t.co/BWZYusn64o
This episode discusses jail-based opioid use disorder treatment, including medication and counseling, and examines the availability of best practices, training, and resources based on a national study of heavily…
This video provides quick summaries of the last 10 articles related to substance use, including wine consumption, opioid use in rural communities, cognitive effects of prescription opioids in older adults, early life…
This episode discusses jail-based opioid use disorder treatment, focusing on best practices, training needs, and policy updates. It highlights the variability in implementation and underscores the importance of…
This video summarizes the key findings from several recent studies, including a cohort analysis comparing buprenorphine and methadone for treating opioid use disorder during pregnancy. The results highlight the benefits…
1.https://t.co/2Nk0bCyeN4 2.https://t.co/lvnApkYcvD @UNODC_PTRS @WHO @MVDrugCourt @StateINL @hrcmv
16. Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, Volume 231, 2022, 109254, ISSN 0376-8716. https://t.co/hzshZ2wuCm
Treatment for opioid use disorder in jail works, and denying it is illegal! Episode 16 reviews an article about in-jail #buprenorphine. Listen on any podcast app. #opioidusedisorder #americanswithdisabilitiesact #AMJC #addictionmedicine https://t.co/hzshZ2x2rU
RT @AddictionMedJC: Episode 16: “Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder” from @DrugAlcoholD…
Episode 16: “Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder” from @DrugAlcoholDep: Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Drug and Alcohol Dependence, Volume 231, 2022, 109254, ISSN 0376-8716. https://t.co/hzshZ2wuCm
RT @AddictionMedJC: The next Addiction Medicine Journal Club podcast is coming on Monday. Download the article from @DrugAlcoholDep now so…
RT @AddictionMedJC: The next Addiction Medicine Journal Club podcast is coming on Monday. Download the article from @DrugAlcoholDep now so…
The next Addiction Medicine Journal Club podcast is coming on Monday. Download the article from @DrugAlcoholDep now so you can join the conversation. “Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.” https://t.co/hzshZ2x2rU
RT @jcoinctc: Results from a recent #JCOIN study found that among incarcerated adults with OUD, the risk of recidivism after jail exit is l…
Results from a recent #JCOIN study found that among incarcerated adults with OUD, the risk of recidivism after jail exit is lower in those offered buprenorphine during incarceration. Read more at https://t.co/vzroGkmzTf
Read newly publlshed article addressing the use of buprenorphine in jail for reducing recidivism and death: https://t.co/BWZYusn64o